[Update, 6/10/13: On Friday, Julie Bosman at The New York Times reported that Jonah Lehrer had signed with Simon & Schuster. As...
Category: self-plagiarism
[Update, 6/10/13: On Friday, Julie Bosman at The New York Times reported that Jonah Lehrer had signed with Simon & Schuster. As far as I know, nobody has disclosed what Lehrer was paid. The signing by a major publisher is, in my view, an affront to journalists who have been playing by the rules.]
The disgraced science writer Jonah Lehrer, who has admitted to lying, fabricating quotes, and other mortal journalistic sins, is now shopping a book proposal--on love.
This news comes from Daniel Engber at Slate,...
4Sep 2012
At 7 p.m. Friday night--the time during the week when people release news items they hope nobody will see--Evan Hansen, the editor-in-chief of Wired.com,...
At 7 p.m. Friday night--the time during the week when people release news items they hope nobody will see--Evan Hansen, the editor-in-chief of Wired.com, announced that a "preliminary Wired review" had found that numerous posts by Jonah Lehrer on his Frontal Cortex blog at Wired did not meet Wired's "editorial standards."
Even for a Friday night release on a holiday weekend between two noisy political conventions and after a hurricane, that's pretty tepid language. Here's what Hansen did not say: The review was intended to do much more than discover whether Lehrer violated "editorial standards." It was intended "to determine whether he [Lehrer] recycled, fabricated, plagiarized, or otherwise breached journalistic ethics." And it...
16Aug 2012
Drugs used to treat mild high blood pressure have not been found to reduce heart attacks, strokes, or deaths, Jeanne Lenzer...
Drugs used to treat mild high blood pressure have not been found to reduce heart attacks, strokes, or deaths, Jeanne Lenzer reports in Slate. The study "turns medical dogma on its head," she writes, in what seems to me to be a very important story. Some 68 million Americans have mild high blood pressure, she reports. The problem could be something called disease creep, which "occurs when patients with risk factors for a condition or milder cases are treated the same as patients with severe cases." The story seems to have received only scattered coverage: A Google search turned up three stories. Not everyone agrees with the findings, but this study should not have been ignored. A nod to Lenzer for staying on top of this...
©2010 Knight Science Journalism at MIT. All Rights Reserved.